Skip to content

Evaluating the relationship between haemodialysis and glucose control in insulin-treated diabetic patients - a pilot study

Evaluating the relationship between haemodialysis and glucose control in insulin-treated diabetic patients - a pilot study - CGM in DM patients on haemodialysis

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON39344
Enrollment
20
Registered
2010-07-06
Start date
2010-11-23
Completion date
Unknown
Last updated
2024-06-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

diabetes mellitus sugar disease

Interventions

None listed

Sponsors

Universitair Medisch Centrum Groningen
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - insulin treated diabetes (type 1 or type 2) on haemodialysis - age 18 years or older - male or female

Exclusion criteria

Exclusion criteria: - secondary form of diabetes - use of oral hypoglycaemic drugs - use of oral/parental glucocorticoids - inability to understand written and oral instructions in Dutch and to adhere to study protocol

Design outcomes

Primary

MeasureTime frame
Mean glucose concentration and area-under-the-curve (AUC) glucose during 24-hour periods, on days with and without haemodialysis

Secondary

MeasureTime frame
o frequency of glucose

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)